Stockwatch: Will Coronavirus Drug Developments Rescue The Sector’s Pricing Reputation?

Mid-Year Drug Price Increases Threaten Biopharma's Coronavirus Reputation Boost

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.